Investigating M1 Aminopeptidases and their role in Alzheimer's Disease

Structural and Bioinformatics Analyses of M1 Aminopeptidases

NIH-funded research University of Massachusetts Lowell · NIH-10437967

This study is looking at certain enzymes that play a role in Alzheimer's disease to find better ways to create treatments that work well without causing unwanted side effects.

Quick facts

Grant typeR15 grant
Study typeNIH-funded research
Funding institutionUniversity of Massachusetts Lowell NIH-funded
Lab location1 site (Lowell, United States)
Project IDNIH-10437967 on NIH RePORTER

What this research studies

This research focuses on understanding the structure and function of M1 aminopeptidases, specifically ERAP1 and IRAP, which are enzymes involved in various biological processes and diseases, including Alzheimer's Disease. The researchers aim to explore how these enzymes can be targeted for therapeutic purposes while minimizing side effects caused by off-target interactions. By analyzing the catalytic domains of these enzymes, the study seeks to develop more effective inhibitors that could potentially improve treatment options for patients with Alzheimer's and related conditions.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals diagnosed with Alzheimer's Disease or related dementias.

Not a fit: Patients with other forms of dementia not related to Alzheimer's may not receive benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to the development of targeted therapies that improve treatment outcomes for patients with Alzheimer's Disease.

How similar studies have performed: Previous research has shown promise in targeting M1 aminopeptidases for therapeutic interventions in various diseases, indicating a potential for success in this approach.

Where this research is happening

Lowell, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer's DiseaseAlzheimer diseaseAlzheimer syndromeAlzheimer's disease dementiaAlzheimers disease
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.